Among participants with no history of major psychopathology, there is no association between semaglutide and depression and suicidality.

Researchers examined data from the Semaglutide Treatment Effect in People with obesity (STEP) trials – STEP 1, 2, 3, and 5.

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, ...

Researchers examined data from the Semaglutide Treatment Effect in People with obesity (STEP) trials—STEP 1, 2, 3, and 5. These studies were crucial in gaining approval from the FDA to use ...

Fink-Jensen, A. (2024). Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology: Post Hoc Analysis of the STEP 1, 2, 3, and 5 Trials. JAMA Internal ...

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or ...

Researchers examined data from the Semaglutide Treatment Effect in People with Obesity (STEP) trials – STEP 1, 2, 3, and 5. These studies were crucial in gaining approval from the FDA to use ...

The team analyzed data from over 3,500 participants across four major clinical trials known as Semaglutide Treatment Effect in People with obesity (STEP) 1, 2, 3, and 4, which were instrumental in ...

Medication does not increase risk for depression, suicidal thoughts or behaviors among adults without known major psychopathology.

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...